Phillip M. Pierorazio

Also affiliated with Penn Center for AIDS Research, University of Pennsylvania Health System, University of Pennsylvania

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Perioperative nivolumab versus observation in patients with renal cell carcinoma undergoing nephrectomy (PROSPER ECOG-ACRIN EA8143): an open-label, randomised, phase 3 study”.

Perioperative nivolumab versus observation in patients with renal cell carcinoma undergoing nephrectomy (PROSPER ECOG-ACRIN EA8143): an open-label, randomised, phase 3 study

The Lancet Oncology(2024)10.1016/s1470-2045(24)00211-0

N/A

1.9DataRank · unranked

86 citations

Se-Eun Kim, Viraj A. Master, David H. McDermott, Lauren C. Harshman, Suzanne Cole +40 more

Plasma Kidney Injury Molecule-1 for Preoperative Prediction of Renal Cell Carcinoma Versus Benign Renal Masses, and Association With Clinical Outcomes

Journal of Clinical Oncology(2024)10.1200/jco.23.00699

N/A

0.494DataRank · unranked

26 citations

Valérie Gaborieau, Samuel M. Niman, Anush Mukeria, Xiaowen Liu, Krishna P. Maremanda +14 more

High-dimensional Cytometry (ExCYT) and Mass Spectrometry of Myeloid Infiltrate in Clinically Localized Clear Cell Renal Cell Carcinoma Identifies Novel Potential Myeloid Targets for Immunotherapy

Molecular & Cellular Proteomics(2020)10.1074/mcp.ra120.002049

N/A

0.242DataRank · unranked

3 citations

Benjamin Murter, John-William Sidhom, Thomas R. Nirschl, David Clark, Li‐Jun Chen +10 more

Active Surveillance for Small Renal Masses

Société Internationale d’Urologie Journal(2022)10.48083/oses5540

N/A

0DataRank · unranked

2 citations

Mark W. Ball, Ravi Barod, Umberto Capitanio, Antonio Finelli, Maria Carmen Mir +5 more

T cell metabolic reprogramming in acute kidney injury and protection by glutamine blockade

JCI Insight(2023)10.1172/jci.insight.160345

N/A

0DataRank · unranked

23 citations

Elizabeth A. Thompson, Sepideh Gharaie, Chirag H. Patel, Johanna T. Kurzhagen, Phillip M. Pierorazio +6 more

Impact of postprogression therapies on overall survival: Recommendations from the 2023 kidney cancer association think tank meeting

Urologic Oncology Seminars and Original Investigations(2024)10.1016/j.urolonc.2024.10.022

N/A

0DataRank · unranked

5 citations

Salvatore La Rosa, Tian Zhang, Phillip M. Pierorazio, Laurence Albigès, Kathryn E. Beckermann +19 more

Tumour size is associated with growth rates of >0.5 cm/year and delayed intervention in small renal masses in patients on active surveillance

British Journal of Urology(2025)10.1111/bju.16651

N/A

0DataRank · unranked

6 citations

Michael E. Rezaee, Roy Elias, Tina Wlajnitz, Sean A. Fletcher, Joseph Cheaib +8 more

PD02-10 THE IMPACT OF SURGEON AND HOSPITAL VOLUME ON 30-DAY OUTCOMES AND COST FOR RENAL CANCER SURGERY

The Journal of Urology(2020)10.1097/ju.0000000000000822.010

N/A

0DataRank · unranked

0 citations

Joseph Cheaib, Hiten D. Patel, Mitchell M. Huang, Michael J. Biles, Michael H. Johnson +4 more

A Clinical Decision Aid to Support Personalized Treatment Selection for Patients with Clinical T1 Renal Masses: Results from a Multi-institutional Competing-risks Analysis

European Urology(2021)10.1016/j.eururo.2021.11.002

N/A

0DataRank · unranked

33 citations

Roman Gulati, Michael A.S. Jewett, Kamel Fadaak, Antonio Finelli, Laura Legere +13 more